About Targeted Technology
Targeted Technology is a venture capital firm founded in 2009. It is primarily based out of San Antonio, United States. As of Nov 2017, Targeted Technology has invested in 15 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Cardiovate Overall, Targeted Technology portfolio has seen 6 acquisitions, namely BioDtech, Vidacare and Santalis Pharma. A lot of funds co-invest with Targeted Technology, with names like Battery Ventures sharing a substantial percentage of its portfolio. Targeted Technology has team of 4 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 3 more
Portfolio Acquisitions
Portfolio Soonicorns
Targeted Technology's List of Top Investments
Targeted Technology has a portfolio of 15 companies. Their most notable investments are in Aerin Medical and BiO2 Medical.Their portfolio spans across United States, Belgium and Ireland. They have invested in Life Sciences, High Tech, Enterprise Applications and 2 other sectors, across stages such as Series A, Series B and 3 more. Here is the list of top investments by Targeted Technology:Developer of therapeutic devices to improve nasal breathing. It offers VivAer and RhinAer non‑invasive treatments that deliver tissue-sparing, temperature-controlled radiofrequency for nasal airway obstruction and chronic rhinitis.
Key facts about Aerin Medical
- Founded Year: 2011
- Location: Sunnyvale (United States)
- Stage: Series E
- Total Funding till date: $176M
- Employee Count: 146 as on Sep 30, 2026
- Investors: CRG, Horizon and 9 Others
- Latest Funding Round: Series E, Dec 13, 2024, $*****
- Highlight: Editors' Pick
2. Xenex
Xenex provides disinfection robots for multiple healthcare purposes. It offers hospital sterilization robots that use strong, ultraviolet lights (termed patented Xenon Pulse or UV technology) to kill infection-causing microorganisms. Their patented room disinfection system reduces the bacterial load that is often associated with an increased risk for healthcare-associated infections (HAIs).
Key facts about Xenex
- Founded Year: 2009
- Location: San Antonio (United States)
- Stage: Series D
- Total Funding till date: $94.4M
- Employee Count: 79 as on Dec 31, 2022
- Investors: Piper Jaffray, RK Ventures and 5 Others
- Latest Funding Round: Series D, Feb 19, 2019, $*****
- Highlight: Editors' Pick
3. StemBioSys
Cell culture technology company advancing regenerative medicine and drug discovery. They specialize in cell-derived matrices that mimic the natural cellular environment, fostering more biologically relevant cell behavior. Their CELLvo™ technology supports stem cell expansion, cardiomyocyte maturation, and improved cell differentiation. They offer a range of cell culture products, including matrices and cells, designed to enhance research outcomes. They also provide custom pre-coating services for cell culture surfaces. Their technology facilitates predictive, cell-based assays, cardiotoxicity screening, and regenerative medicine research. They focus on innovation and collaboration to provide researchers with advanced tools for cell culture and analysis.
Key facts about StemBioSys
- Founded Year: 2010
- Location: San Antonio (United States)
- Annual Revenue: $0 - $1M as on Dec 31, 2023
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $14.5M
- Employee Count: 11 as on Sep 30, 2026
- Investors: JLABS, Targeted Technology and 3 Others
- Latest Funding Round: Grant (prize money), Feb 13, 2025, $*****
- Highlight: Editors' Pick
4. DNAtrix
DNAtrix is a clinical stage company developing virus-driven immunotherapies for cancer. Its lead product, DNX-2401 is a conditionally replicative oncolytic virus being studied in clinical trials for recurrent glioblastoma (brain cancer) and is in Phase 3. Its pipeline includes viruses armed with potent immunomodulatory molecules that augment a patient’s immune system to trigger an aggressive anti-tumor T-cell response .
Key facts about DNAtrix
- Founded Year: 2005
- Location: Houston (United States)
- Stage: Series C
- Total Funding till date: $43M
- Employee Count: 4 as on Sep 30, 2026
- Investors: FDA, Morningside and 7 Others
- Latest Funding Round: Grant (prize money), Sep 01, 2022, $*****
- Highlight: Editors' Pick
5. BioDtech
BioDtech develops new technically superior products for the bioresearch and bioprocess markets for the detection, neutralization and removal of endotoxins. It offers reagents to develop assays for endotoxin detection and the ability to remove and neutralize endotoxin. It also provides services to detect and remove endotoxins from aqueous solutions using its EndoBind-R technology. It has negotiated a license agreement with the National University of Singapore for worldwide rights to develop these products.
Key facts about BioDtech
- Founded Year: 2003
- Location: Birmingham (United States)
- Stage: Acquired
- Total Funding till date: $1.6M
- Employee Count: 3 as on Sep 30, 2026
- Investors: Greer Capital Advisors, Targeted Technology and 2 Others
- Latest Funding Round: Grant (prize money), Sep 01, 2014, $*****
- Highlight: Acquired
Targeted Technology's Year-on-Year Investment Trends
Targeted Technology has invested in 15 companies over the last 17 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Cardiovate and most recent follow-on round was in Xenex.Targeted Technology's Investments by Stage
Targeted Technology has made 4 investments in Series A stage with an average round size of $6.5M, 3 investments in Series B stage with an average round size of $12.3M, 2 investments in Seed stage with an average round size of $1M, 1 investment in Series C stage with an average round size of $16.7M and 1 investment in Series D stage with an average round size of $7.6M.Stage of entry | No. of Investments |
|---|---|
Series A | 4 |
Series B | 3 |
Seed | 2 |
Series C | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Targeted Technology's Investments by Sector
Targeted Technology has a diverse portfolio, with companies operating in the Life Sciences, Consumer, Enterprise Applications, High Tech and Retail. Notably, it has invested in 15 Tech companies, 13 Enterprise (B2B) companies, 4 Tech hardware companies and at least 3 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 10 |
Consumer | 1 |
Enterprise Applications | 1 |
High Tech | 1 |
Retail | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Targeted Technology's Investments by Geography
Targeted Technology has made most investments in United States (9), followed by Belgium where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 9 |
Belgium | 1 |
Ireland | 1 |
Note: We have considered here, only first round of investments
Targeted Technology's recent investments
Targeted Technology has not made any investment in 2026 so far.Here are the most recent investments by Targeted Technology:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 23, 2017 | United States | Seed | 8193 | ||
Jun 06, 2017 | Ireland | Series B | 8461 | - | |
Mar 21, 2016 | United States | Series C | 8266 | - | |
Feb 01, 2016 | United States | Series A | 7943 | - | |
Apr 01, 2015 | United States | Series A | 4260 | - |
Acquired companies in Targeted Technology's Portfolio
6 companies from Targeted Technology's portfolio have been acquired. The most recent acquisition was BioDtech in Jul 2020 by Predictive Oncology for $*****.Here are Targeted Technology's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 06, 2020 | - | - | 9591 | |
Apr 07, 2020 | Jun 06, 2017 | Series B | 2943 | |
Dec 20, 2016 | Jul 11, 2011 | Seed | 6289 | |
Jul 17, 2015 | - | - | 2666 | |
Jun 17, 2015 | - | - | 7841 |
Team profile of Targeted Technology
Targeted Technology has a team of 4 members including 4 Partners located in United States. Targeted Technology's team does not sit on the board of any company as of now.Here is a list of all team members in Targeted Technology:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Antonio | - | ||
Partner | Birmingham | - | ||
Partner | San Antonio | - | ||
Partner | San Antonio | - | - |
Co-investors of Targeted Technology
Over the past 17 years, 32 investors have co-invested in Targeted Technology's portfolio companies. This includes only funds.
- Invested before Targeted Technology: Metric Medical Devices, Mercury Fund and 5 others have invested in rounds before Targeted Technology. There is 1 company where Metric Medical Devices has invested before Targeted Technology and 1 company where Mercury Fund has invested before Targeted Technology.
- Top Co-investors of Targeted Technology: 7 investors entered a company along with Targeted Technology. These include investors like Battery Ventures (1 company).
- Invested after Targeted Technology: A total of 18 investors have invested in Targeted Technology's portfolio after their investments. Top Investors include CRG (1 company), Horizon (1 company) and Questa Capital (1 company).
Recent News related to Targeted Technology
•
Regenerative Vessel Stent Dev Cardiovate Raises USD 1 MillionMedical Buyer•Nov 23, 2017•Cardiovate, Targeted Technology, Innovation UT System
•
Aerin Medical Closes $16.7M Series C Financing |FinSMEsFinSMEs•Mar 22, 2016•Aerin Medical, Targeted Technology
•
StemBioSys Closes $8 Million Series A Financing | Business WireBusiness Wire•Apr 14, 2015•StemBioSys, Targeted Technology
•
StemBioSys meets $8 million goal in initial financing - San Antonio Express-NewsExpressnews•Apr 14, 2015•StemBioSys, Metric Medical Devices, Targeted Technology
•
StemBioSys of San Antonio Lands $8 Million in Funding - SiliconHillsApr 14, 2015•StemBioSys, Targeted Technology
•
Venture Capital Access Online | Venture Capital NewsVCA Online•Oct 14, 2014•DNAtrix, Mercury Fund, Targeted Technology, Morningside
•
Xenex Raises $11.3M For Germ Zapping SystemTexasTechPulse•Nov 21, 2013•Xenex, Battery Ventures, Targeted Technology, RK Venture and 1 other
•
Soluble Therapeutics, Inc. closes a $1MM Round of VC Funding led by The Birmingham Technology Fund, Greer Capital, and Targeted Technology FundSoluble Therapeutics•Jul 11, 2011•Soluble Therapeutics, Greer Capital Advisors, Targeted Technology
•
•
Vidacare Raises $7.6MTexasTechPulse•Jul 14, 2009•Vidacare, Tullis Health Investors, Incyte Ventures, Targeted Technology and 1 other
